ENDPOINTS

Odyssey Therapeutics withdraws IPO plans as public markets remain frozen

Immunology biotech Odyssey Therapeutics has withdrawn its plans to go public via an IPO, according to a regulatory filing on Monday evening. The biotech didn't appear to immediately need the cash. Per its most recent ...

Jun 10, 2025 - 10:10
 0
Odyssey Therapeutics withdraws IPO plans as public markets remain frozen
Immunology biotech Odyssey Therapeutics has withdrawn its plans to go public via an IPO, according to a regulatory filing on Monday evening. The biotech didn't appear to immediately need the cash. Per its most recent ...
Read More

Tags:

Previous Article

An Indian astronaut is about to visit the ISS for the 1st time ever

Next Article

Migrant status compounds inequality for ethnic minority NHS staff, study finds

Related Posts

About 5% of CBER and CDER left after FDA staff cuts, analysis finds

About 5% of CBER and CDER left after FDA staff cuts, an...

May 23, 2025  0

Cigna, Novo Nordisk offer lower GLP-1 prices

Cigna, Novo Nordisk offer lower GLP-1 prices

May 22, 2025  0

Weight loss startup Calibrate replaces CEO in leadership shakeup 

Weight loss startup Calibrate replaces CEO in leadershi...

May 20, 2025  0